FDA moots medical product advertising initiative
This article was originally published in Clinica
Executive Summary
The US FDA is in the early stages of forming an inter-centre co-ordinating group for the regulation of medical product advertising. The group will facilitate the development and implementation of appropriate policies and procedures in this area, FDA staffers said, ensuring more uniformity across the centres in how promotional materials are regulated. It will also be able to provide resources that might not be available at a single centre, they added.